Thymulin 20mg

For research use only — not for human or veterinary use.

Analytical Verification (COA)

Each batch of Thymulin supplied by Grail Formula undergoes independent third-party laboratory verification to confirm compound identity, assay content, purity and microbiological safety. Analytical testing for this batch was performed by Liquilabs s.r.o. (Czechia) using validated chromatographic and spectrometric techniques. Batch: GF-THYMU20-B241 Key analytical results include:

• Assay Content: 20.299 mg
• Identification – Retention Time: 0.994
• Identification – Spectrum: 991
• Purity: greater than 99.8 percent
• Bacterial Endotoxins: below 0.001 EU per mg
• Total Aerobic Microbial Count: not detected
• Total Yeast and Mold Count: not detected

Independent heavy metal screening confirmed no detectable levels of arsenic, cadmium, cobalt, lead, nickel, mercury or vanadium. These analytical procedures ensure traceability, purity verification and laboratory-grade compound consistency.

Product Overview

Thymulin is a synthetic peptide research compound frequently studied in controlled laboratory environments investigating immune regulatory pathways and thymic peptide signalling. The peptide belongs to a class of thymic regulatory peptides associated with immune system communication and cellular regulatory processes. This preparation contains 20 mg of high purity lyophilized peptide supplied in a sealed research vial. The lyophilization process preserves peptide stability and allows researchers to reconstitute the compound for controlled in vitro experimentation. Because of its defined peptide structure and stable analytical profile, Thymulin has become a widely referenced compound in experimental immunological research models.

Compound Overview

Thymulin is a thymic peptide associated with immune system regulatory signalling and cellular communication processes. The thymus gland plays a central role in immune cell maturation, particularly in the development and differentiation of T lymphocytes. Research involving Thymulin frequently explores peptide-mediated immune regulation and cellular signalling mechanisms involved in immune response pathways. Due to its defined molecular structure and role within thymic signalling systems, the compound is often used in laboratory studies examining immune regulatory networks.

Historical Background and Scientific Context

Scientific interest in thymic peptides expanded during the twentieth century as researchers began identifying molecules produced by the thymus that influence immune system development. During this period, multiple thymic peptides were identified and investigated for their roles in immune cell signalling and regulatory pathways. Thymulin emerged as one of the peptides studied in relation to thymic hormone activity and immune regulatory signalling systems. Advances in peptide synthesis enabled researchers to produce synthetic forms of thymic peptides to study immune regulatory pathways in controlled laboratory settings.

Mechanistic Focus in Research

Within experimental laboratory settings, Thymulin is commonly studied in relation to immune regulatory signalling pathways. Research investigations commonly explore the compound in experimental models examining:

• Thymic peptide signalling pathways
• T-cell regulatory processes
• Immune system communication networks
• Peptide-mediated cellular signalling
• Immune regulatory pathway modelling
• Comparative thymic peptide research
• Cellular immune signalling mechanisms

These experimental models allow scientists to investigate molecular regulatory mechanisms involved in immune system signalling and cellular communication.

Research Applications

In controlled research environments, Thymulin may be utilised in experimental models designed to explore immune signalling systems and thymic peptide regulatory processes. Examples of research applications include:

• Immune signalling pathway investigation
• T-cell related research models
• Peptide signalling studies
• Comparative immunological compound evaluation
• Intracellular immune network modelling
• Regulatory peptide interaction research
• Controlled in vitro immune system studies

Grail Formula Quality

Every Grail Formula research compound is produced under strict quality control procedures designed to support reliable laboratory experimentation. Each batch undergoes independent analytical testing to verify:

• Compound identity
• Assay accuracy
• Purity confirmation
• Microbial safety
• Endotoxin levels
• Heavy metal screening
• Full batch traceability

All testing is performed by independent laboratories to ensure transparent verification and reproducible research material.

Research Use Limitation

• Used solely for in vitro experiments
• Not permitted for clinical trials involving humans
• Not permitted for human or veterinary administration
• Not permitted for investigational human use

Independently verified by Liquilabs s.r.o. (Czechia)
Validated assay content 20.299 mg
Purity greater than 99.8 percent
Retention time and spectral identity confirmation
Endotoxin levels below 0.001 EU per mg
No detectable microbial contamination
No detectable heavy metals
For research use only — not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.